SRC and colorectal carcinoma: miR-9 suppresses the high glucose concentration-induced proliferation, migration, and EMT of CRC cells, by inhibiting insulin-like growth factor 1 receptor (IGF1R)/Src activation and upregulating E-cadherin expression [105].